Cytomx Thera (CTMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Sales | 8,279 | 10,712 | 9,013 | 29,485 | 11,471 |
| Gross Profit | 8,279 | 10,712 | 9,013 | 29,485 | 11,471 |
| Operating Expenses | 45,658 | 36,430 | 40,246 | 46,050 | 37,281 |
| Operating Income | -37,379 | -25,718 | -31,233 | -16,565 | -25,810 |
| Other Income | 1,503 | 2,019 | 2,273 | 2,435 | 2,489 |
| Pre-tax Income | -35,876 | -23,699 | -28,960 | -14,130 | -23,321 |
| Income Tax | -421 | N/A | N/A | -6 | 8,912 |
| Net Income Continuous | -35,455 | -23,699 | -28,960 | -14,124 | -32,233 |
| Net Income | $-35,455 | $-23,699 | $-28,960 | $-14,124 | $-32,233 |
| EPS Basic Total Ops | -0.79 | -0.52 | -0.64 | -0.31 | -0.75 |
| EPS Basic Continuous Ops | -0.78 | -0.52 | -0.64 | -0.31 | -0.75 |
| EPS Diluted Total Ops | -0.79 | -0.52 | -0.64 | -0.31 | -0.75 |
| EPS Diluted Continuous Ops | -0.78 | -0.52 | -0.64 | -0.31 | -0.75 |
| EBITDA(a) | $-37,036 | $-25,597 | $-31,260 | $-16,625 | $-25,898 |